Bernstein Reiterates Outperform on UnitedHealth (UNH) Amid Medicare Advantage Volatility

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the stocks with the lowest forward PE ratios. Following notable stock volatility caused by Medicare Advantage (MA) advance rate announcements, Bernstein SocGen Group reiterated its Outperform rating and $405 price target for UnitedHealth Group Incorporated (NYSE:UNH) on January 30.

Analyst Lance Wilkes noted five key market questions regarding this, including justifications for the surprise advance rate, potential consequences on Medicare Advantage margins, and various projections of the effects on UnitedHealth’s earnings per share.

Moreover, on January 29, TD Cowen reduced its price target for UnitedHealth Group Incorporated (NYSE:UNH) to $311 from $338, retaining a Hold rating on the company’s shares. The firm upgraded its earnings per share projections for UnitedHealth Group Incorporated (NYSE:UNH), expecting $17.53 in 2026 and $19.44 in 2027, compared to prior projections of $17.27 and $19.95.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.